MY137446A - Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain - Google Patents
Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated painInfo
- Publication number
- MY137446A MY137446A MYPI20022692A MY137446A MY 137446 A MY137446 A MY 137446A MY PI20022692 A MYPI20022692 A MY PI20022692A MY 137446 A MY137446 A MY 137446A
- Authority
- MY
- Malaysia
- Prior art keywords
- pain
- cluster
- preventing
- migraine headache
- treating neuropathic
- Prior art date
Links
- 208000006561 Cluster Headache Diseases 0.000 title abstract 2
- 208000019695 Migraine disease Diseases 0.000 title abstract 2
- 208000002193 Pain Diseases 0.000 title abstract 2
- 208000018912 cluster headache syndrome Diseases 0.000 title abstract 2
- 206010027599 migraine Diseases 0.000 title abstract 2
- 208000004296 neuralgia Diseases 0.000 title abstract 2
- 208000021722 neuropathic pain Diseases 0.000 title abstract 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical compound C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- -1 AMINO Chemical class 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical class N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
THIS INVENTION IS DIRECTED TO A METHOD FOR PREVENTING OR TREATING NEUROPATHIC PAIN AND CLUSTER AND MIGRAINE HEADACHE-ASSOCIATED PAIN COMPRISING ADMINISTERING TO A SUBJECT IN NEED THEREOF A THERAPEUTICALLY EFFECTIVE AMOUNT OF AN ENANTIOMER OF FORMULA (I) SUBSTANTIALLY FREE OF OTHER ENANTIOMERS OR AN ENANTIOMERIC MIXTURE WHEREIN AN ENANTIOMER OF FORMULA (I) PREDOMINATES: WHEREIN PHENYL IS SUBSTITUTED AT X WITH ONE TO FIVE HALOGEN ATOMS INDEPENDENTLY SELECTED FROM THE GROUP CONSISTING OF FLUORINE, CHLORINE, BROMINE AND IODINE; AND; R1 AND R2 ARE INDEPENDENTLY SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND C1-C4 ALKYL; WHEREIN C1-C4 ALKYL IS OPTIONALLY SUBSTITUTED WITH PHENYL (WHEREIN PHENYL IS OPTIONALLY SUBSTITUTED WITH SUBSTITUENTS INDEPENDENTLY SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, HALOGEN, C1-C4 ALKYL, C1-C4 ALKOXY, AMINO, NITRO AND CYANO).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30568701P | 2001-07-16 | 2001-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY137446A true MY137446A (en) | 2009-01-30 |
Family
ID=35160899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20022692 MY137446A (en) | 2001-07-16 | 2002-07-16 | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
Country Status (2)
| Country | Link |
|---|---|
| MY (1) | MY137446A (en) |
| ZA (1) | ZA200401155B (en) |
-
2002
- 2002-07-16 MY MYPI20022692 patent/MY137446A/en unknown
-
2004
- 2004-02-12 ZA ZA200401155A patent/ZA200401155B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200401155B (en) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU67703A (en) | Carbamate compounds for use in preventing or treating movement disorders | |
| MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| YU68003A (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| IL157590A0 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| AU7349301A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| IL157594A0 (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
| PL368112A1 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| IL159847A0 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| MY137446A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| MY136347A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders |